MarketPulse

drug launch

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Tenax Therapeutics Appoints Seasoned Pharma Executive Timothy Healey as CCO

Tenax Therapeutics appoints veteran pharma executive Timothy Healey as Chief Commercial Officer to lead TNX-103 market launch preparations as Phase 3 trials advance.
TENXPhase 3 clinical trialcommercial strategy
BenzingaBenzinga··Vandana Singh

Novo Nordisk Widens Obesity Drug Gap as Lilly's Pill Launch Stumbles

Eli Lilly's obesity pill logged 1,390 first-week prescriptions versus Novo Nordisk's 3,071 in four days, as $NVO maintains commanding 113,354 weekly Wegovy prescriptions.
LLYNVOmarket sharepharmaceutical competition
The Motley FoolThe Motley Fool··Jonathan Ponciano

RTW's $116M Cogent Bet Amplifies Biotech Rally Ahead of Key FDA Decision

RTW Investments purchases $116M stake in Cogent Biosciences, raising position to 2.7% of AUM amid 360% stock surge and anticipated 2026 FDA decision on lead drug.
COGTFDA approvalinstitutional investment